Market Resilience: Citius Pharmaceuticals Inc (CTXR) Finishes Weak at 0.20, Down -39.10

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Citius Pharmaceuticals Inc (NASDAQ: CTXR) closed the day trading at $0.20 down -39.10% from the previous closing price of $0.33. In other words, the price has decreased by -$39.10 from its previous closing price. On the day, 10.9 million shares were traded. CTXR stock price reached its highest trading level at $0.3279 during the session, while it also had its lowest trading level at $0.1875.

Ratios:

For a better understanding of CTXR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.75 and its Current Ratio is at 6.75. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on November 30, 2021, initiated with a Buy rating and assigned the stock a target price of $4.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTXR now has a Market Capitalization of 36145000 and an Enterprise Value of 19154280.

Stock Price History:

Over the past 52 weeks, CTXR has reached a high of $1.07, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -53.52%, while the 200-Day Moving Average is calculated to be -69.26%.

Shares Statistics:

Over the past 3-months, CTXR traded about 1.15M shares per day on average, while over the past 10 days, CTXR traded about 3332110 shares per day. A total of 180.72M shares are outstanding, with a floating share count of 168.40M. Insiders hold about 6.82% of the company’s shares, while institutions hold 12.91% stake in the company. Shares short for CTXR as of 1730332800 were 11787635 with a Short Ratio of 10.29, compared to 1727654400 on 12768363. Therefore, it implies a Short% of Shares Outstanding of 11787635 and a Short% of Float of 7.000000000000001.

Earnings Estimates

The firm’s stock currently is rated by 1.0 analysts. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.

Analysts are recommending an EPS of between -$0.19 and -$0.26 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is $0.19, with 1.0 analysts recommending between $0.19 and $0.19.

Revenue Estimates

Based on 2 analysts’ estimates, the company’s revenue will be $68.99M in the next fiscal year. The high estimate is $92.1M and the low estimate is $45.89M.

Most Popular